M. G. Matera (Naples, Italy), M. Belvisi (London, United Kingdom)
Roflumilast N-oxide reduces human fibroblast function
J. Klar, F. Sabatini, E. Schatton, B. Burgbacher, G. A. Rossi, A. Hatzelmann, H. Tenor (Konstanz, Germany; Genova, Italy)
|   |
p38 MAPK/MSK1/CREB signal pathway involves in transforming growth factor-β-induced heme oxygenase-1 expression in human lung epithelial cells
B. C. Chen, C. H. Lin, Y. T. Lu (Taipei, Taiwan, Province Of China)
| |
Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
K. Racké, A. Bahulayan, S. Matthiesen (Bonn, Germany)
| |
Effect of tiotropium on cough reflex sensitivity in acute viral cough
P. Dicpinigaitis, L. Spinner, G. Santhyadka (New York, United States Of America)
| |
Effect of discontinuation and readministration of inhaled human insulin on pulmonary safety in adult diabetes patients
R. Riese, J. Teeter (New London, CT, United States Of America)
| |
Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism
D. Yang, G. Zhao, T. Wu, H. Zhou, Y. Ji, Z. Zhang (Shanghai, Dalian, China)
| |
Lung deposition of 99mTc-DTPA delivered with an adaptive aerosol delivery system
K. Nikander, I. Prince, S. Coughlin, S. Warren, G. Taylor (Chichester, Cardiff, United Kingdom)
| |
Psychometric evaluation of the asthma life impact scale (ALIS)
D. Meads, S. McKenna, D. Revicki, R. Flood, A. Glendenning (Manchester, Horsham, United Kingdom; Bethesda, United States Of America)
| |
Treatment of termoinhalational trauma consequences
S. Degtyareva, E. Shmelev (Moscow, Russian Federation)
| |
Dry powder inhalers in asthma and COPD. Which factors determine the frequency of handling errors?
S. Wieshammer, J. Dreyhaupt (Offenburg, Heidelberg, Germany)
| |
Acute tracheobronchitis in children: objective efficacy of fenspiride
S. Gerasimov (Lviv, Ukraine)
| |
Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease
T. Hisada, T. Ishizuka, H. Aoki, N. Yanagitani, Y. Koike, K. Kaira, M. Utsugi, A. Ono, Y. Shimizu, N. Sunaga, K. Seki, K. Dobashi, M. Mori (Maebashi, Japan)
| |
Effectiveness of thrombolytic therapy in pulmonary thromboembolism
R. Unver, G. Okumus, E. Kiyan, H. Issever, O. Arseven (Istanbul, Turkey)
| |
Peptic ulcers in patients on long term inhaled steroids
Z. Stojanovski, B. Janackov, D. Andjelkovic, J. Minov, G. Andonov (Skopje, Kumanovo, Fyrom)
| |
The state of patients with chronic obstructive pulmonary disease (COPD)
S. Farckhutdinov, L. Abdrachmanova, A. Mirchaidarov, R. Zakirova (Ufa, Russian Federation)
| |
Asthma Control Test (ACT) scores and FENO correlation
B. Gemicioglu, B. Z. Yildirim, I. Dogan, S. Serbest, K. Guven (Istanbul, Turkey)
| |
Nasal beclomethasone plus loratadine in patients with rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial
Z. Paunovic (Nis, Serbia And Montenegro)
| |
CFD simulation of particle deposition in imaged tracheobronchial airways
M. Pichelin, G. Caillibotte, A. Makarenko, I. Katz, G. Sbirlea-Apiou (Jouy-en-Josas, France)
| |
Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
J. Mitchell, C. Doyle, M. Nagel, R. Sharpe (London, ON, Canada; Nottingham, United Kingdom)
| |
The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group
I. Ilyuk, V. Malenky (Vinnitsa, Ukraine)
| |